10X GENOMICS, INC. - Annual Financials - Cash Flow (SEC)

Updated on January 3, 2026.

Related Topics: SEC Topic List.

Data Source: SEC.

See details in table below.

You can see similar for other companies.

10X GENOMICS, INC. - Annual Cash Flow (In Thousands of USD, Except Per Share Amounts)

Breakdown	2024-12-31	2023-12-31	2022-12-31
Net loss	-182627	-255099	-166000
Stock-based compensation expense	140749	166950	136848
Depreciation and amortization	35879	35512	25368
Lease and asset impairment charges	3054	9845	0
Amortization of right-of-use assets	7829	8107	7638
Realized loss on marketable securities	-3	-1718	0
Other	523	427	1957
Accounts receivable	-26951	10613	18948
Inventory	9777	-7871	21192
Prepaid expenses and other current assets	1901	2429	4495
Other noncurrent assets	1084	678	-925
Accounts payable	-3354	-6017	5858
Accrued compensation and other related benefits	3654	-2637	1114
Deferred revenue	11209	10932	3350
Accrued expenses and other current liabilities	-12736	28301	3336
Operating lease liability	-12484	-8671	-6423
Other noncurrent liabilities	776	1284	-2942
Net cash provided by (used in) operating activities	6664	-15197	-33606
Proceeds from sales of marketable securities	3856	100191	49117
Proceeds from maturities of marketable securities	25782	82825	18528
Purchases of property and equipment	12393	48601	131661
Purchase of intangible assets	1000	923	0
Acquisition of business, net of cash acquired	0	0	4000
Purchase of marketable securities	48876	0	282871
Net cash (used in) provided by investing activities	-32631	133492	-350887
Payments on technology license financing arrangement	0	5814	5409
Issuance of common stock from exercise of stock options and employee stock purchase plan purchases	10914	19483	21226
Net cash provided by financing activities	10914	13669	15817
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	-164	-33	-44
Net (decrease) increase in cash, cash equivalents, and restricted cash	-15217	131931	-368720
Cash, cash equivalents, and restricted cash at beginning of year	344067	359284	227353
Cash, cash equivalents, and restricted cash at end of year	344067	359284	227353
Cash paid for interest	0	436	841
Cash paid for taxes	5641	4927	3925
Purchases of property and equipment included in accounts payable, accrued expenses and other current liabilities	1351	3324	26750
Right-of-use assets obtained in exchange for new operating lease liabilities	0	6518	16562